» Articles » PMID: 35742357

Healing Process, Pain, and Health-Related Quality of Life in Patients with Venous Leg Ulcers Treated with Fish Collagen Gel: A 12-Week Randomized Single-Center Study

Overview
Publisher MDPI
Date 2022 Jun 24
PMID 35742357
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to assess the effectiveness of fish skin collagen and its impact on healing, pain intensity, and quality of life in patients with venous leg ulcers (VLUs). This study included 100 adults with VLUs. Eligible patients were randomized to either tropocollagen gel treatment (group A, = 47) or placebo alone (group B, = 45). We applied the gel to the periwound skin for 12 weeks. All groups received standard wound care, including class 2 compression therapy and wound hygiene procedures. We assessed the healing rate (cm/week) and quality of life (QoL) using the Skindex-29 and CIVIQ scales. In group A, more ulcers healed, and the healing rate was faster. In both study groups, patients showed a significant improvement in quality of life after the intervention, but there was a greater improvement in the tropocollagen group. In group A, the greatest improvement was related to physical symptoms and the pain dimension. This study showed that the application of fish collagen gel to the periwound skin improves the healing process and QoL in patients with VLUs. The 12-week treatment with collagen reduced the severity of physical complaints, pain, and local skin symptoms, which determined the quality of life in patients with VLUs to the greatest extent.

Citing Articles

The Promoting Effect of Animal Bioactive Proteins and Peptide Components on Wound Healing: A Review.

Fan X, Ye J, Zhong W, Shen H, Li H, Liu Z Int J Mol Sci. 2024; 25(23).

PMID: 39684273 PMC: 11640812. DOI: 10.3390/ijms252312561.


A state-of-the-art review of quality-of-life assessment in venous disease.

Cleman J, Xia K, Haider M, Nikooie R, Scierka L, Romain G J Vasc Surg Venous Lymphat Disord. 2023; 12(4):101725.

PMID: 38128828 PMC: 11523418. DOI: 10.1016/j.jvsv.2023.101725.


Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds.

Pecova J, Rohlikova V, Smoldasova M, Marek J Pharmaceutics. 2023; 15(9).

PMID: 37765236 PMC: 10536360. DOI: 10.3390/pharmaceutics15092268.


Influence of pain on the quality of life in patients with venous ulcers: Cross-sectional association and correlation study in a brazilian primary health care lesions treatment center.

Junior S, Catarina de Souza Oliveira A, Dantas Araujo M, Dantas B, Sanchez M, Torres G PLoS One. 2023; 18(8):e0290180.

PMID: 37582120 PMC: 10426926. DOI: 10.1371/journal.pone.0290180.


Correlation between Generic and Disease-Specific Quality of Life Questionnaires in Patients with Venous Ulcerations: A Cross-Sectional Study Carried out in a Primary Health Care Setting in Brazil.

de Oliveira Viana Pereira D, Catarina de Souza Oliveira A, Junior S, Jacinto M, Dionisio A, Lima A Int J Environ Res Public Health. 2023; 20(4).

PMID: 36834277 PMC: 9961915. DOI: 10.3390/ijerph20043583.


References
1.
Szewczyk M, Jawien A, Migdalski A, Piotrowicz R, Grzela T, Brazis P . Predicting time to healing by anatomical assessment of venous pathology. Med Sci Monit. 2009; 15(2):CR74-81. View

2.
Moura R, Goncalves G, Navarro T, Britto R, Dias R . Relationship between quality of life and the CEAP clinical classification in chronic venous disease. Rev Bras Fisioter. 2010; 14(2):99-105. View

3.
Jockenhofer F, Knust C, Benson S, Schedlowski M, Dissemond J . Influence of placebo effects on quality of life and wound healing in patients with chronic venous leg ulcers. J Dtsch Dermatol Ges. 2019; 18(2):103-109. DOI: 10.1111/ddg.13996. View

4.
Launois R, Reboul-Marty J, Henry B . Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res. 1996; 5(6):539-54. DOI: 10.1007/BF00439228. View

5.
Szewczyk M, Moscicka P, Jawien A, Cwajda-Bialasik J, Cierzniakowska K, Slusarz R . Quality of life in patients with leg ulcers or skin lesions - a pilot study. Postepy Dermatol Alergol. 2016; 32(6):465-9. PMC: 4697015. DOI: 10.5114/pdia.2014.40983. View